ABOUT THE SERVICE
Immunovant is developing a portfolio of anti-FcRn therapies targeting autoimmune diseases. These therapies aim to modulate immune responses and improve patient outcomes.
Information is owner-confirmed
Last updated 1 month ago
Price range